SPRO logo

SPRO
Spero Therapeutics Inc

2,743
Mkt Cap
$140.68M
Volume
214,374.00
52W High
$3.22
52W Low
$0.5052
PE Ratio
20.42
SPRO Fundamentals
Price
$2.43
Prev Close
$2.45
Open
$2.41
50D MA
$2.35
Beta
0.85
Avg. Volume
321,770.76
EPS (Annual)
$0.1452
P/B
2.32
Rev/Employee
$2.38M
$100.19
Loading...
Loading...
News
all
press releases
Spero Therapeutics (NASDAQ:SPRO) Upgraded by Wall Street Zen to "Strong-Buy" Rating
Wall Street Zen raised shares of Spero Therapeutics from a "hold" rating to a "strong-buy" rating in a research note on Sunday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Posts Earnings Results, Beats Estimates By $0.73 EPS
Spero Therapeutics (NASDAQ:SPRO - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts...
MarketBeat·8d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Downgraded by Wall Street Zen to "Hold"
Wall Street Zen lowered shares of Spero Therapeutics from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·14d ago
News Placeholder
Spero Therapeutics (SPRO) Expected to Announce Earnings on Thursday
Spero Therapeutics (NASDAQ:SPRO) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-spero-therapeutics-inc-stock...
MarketBeat·16d ago
News Placeholder
Spero Therapeutics, Inc. (NASDAQ:SPRO) Sees Large Decline in Short Interest
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) was the target of a large decrease in short interest in February. As of February 27th, there was short interest totaling 574,027 shares, a...
MarketBeat·19d ago
News Placeholder
Short Interest in Spero Therapeutics, Inc. (NASDAQ:SPRO) Declines By 24.0%
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) was the recipient of a large decline in short interest during the month of February. As of February 13th, there was short interest totaling...
MarketBeat·1mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200-Day Moving Average - Should You Sell?
Spero Therapeutics (NASDAQ:SPRO) Shares Cross Above 200 Day Moving Average - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Esther Rajavelu Sells 87,917 Shares of Spero Therapeutics (NASDAQ:SPRO) Stock
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 87,917 shares of the firm's stock in a transaction dated Friday, February 6th. The shares were sold at an average...
MarketBeat·2mo ago
News Placeholder
Insider Selling: Spero Therapeutics (NASDAQ:SPRO) Insider Sells 18,442 Shares of Stock
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 18,442 shares of the company's stock in a transaction on Monday, February 2nd. The shares were sold at an average...
MarketBeat·2mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Insider Sells 18,442 Shares
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 18,442 shares of the business's stock in a transaction dated Monday, February 2nd. The stock was sold at an...
MarketBeat·2mo ago
<
1
2
...
>

Latest SPRO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.